Dr. Zorn is a former associate professor of urology at the University of Montreal (CHUM) and the University of Chicago, sub-specializing in robotic surgery and BPH surgical care.
Dr. Zorn’s career has consistently been hallmarked by research and innovation. Among his many firsts, he was the first in Canada and Québec to use many new BPH technologies including Greenlight XPS, Rezum, iTind, Optilume and Aquablation. Furthermore, Dr. Zorn is actively involved in investigational trial devices including Zenflow, ProVee and Urocross.
He has also been the first in Canada to introduce cutting-edge technologies including the Clarius and ButterflyIQ point-of care ultrasound (POCUS), as well as disposable AMBU4 cystoscopes for faster patient care and safety.
He is among the first physicians globally to be named as a Center of Excellence for Rezum and Greenlight vaporization and VIT (vapor incision technique). He is an international speaker and surgical trainer for these techniques.
Dr. Zorn is the senior author of the Male LUTS/BPH guidelines for the 2018 and 2022 Canadian Urological Association and has been an invited reviewer of the American Urological Association BPH guidelines.
He has also helped create national online programs in robotic prostate cancer care and rehabilitation as well as a BPH patient decision aid tool.
Over the past 17 years, he has now authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. With such accolades, Dr. Zorn has become a sought-after speaker, teacher and researcher. He has travelled to lecture, teach and proctor surgery around the world, and is intimately involved with the development of several new, pioneering BPH technologies.
Dr. Zorn attended McGill University for his pre-med Bachelor program, then completed his medical degree followed by residency in urological surgery at McGill. He is a former associate professor of the University of Montreal and the University of Chicago.
He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2005.
Dr. Zorn also became American Board of Urology certified in urology and a fellow of the American College of Surgeons. After remaining on faculty at the University of Chicago until 2009, Dr. Zorn returned to Canada in 2010 to join the faculty of the Division of Urology at the University of Montreal.
Over the next 14 years, Dr. Zorn would help develop the MIS robotics and BPH fellowship, onboard the Greenlight XPS laser program and conduct several clinical BPH trials. These include the Zenflow Spring System (zencast and breeze trials) as well as the WATER II PROCEPT Aquablation studies. In 2024, Dr. Zorn retired from his position at the University of Montreal to dedicate his full clinical practice to BPH Canada.
As an attending urologist, he has cultivated a clinical and research interest in localised prostate cancer, robotic surgery (over 3500 robotic prostatectomy cases performed), artificial intelligence, men’s health, sexual dysfunction and BPH.
He holds a number of roles including medical director of robotic surgery and fellowship director for robotics and MIS since 2011. He is also the founder of intuitiveurology.com (a global platform for resident urological education materials and self-testing) as well as BPHCanada.com.
Dr. Zorn’s scope of services for men’s health also extends to no-needle no-scalpel vasectomy, male circumcision and hydrocele.
Dr. Zorn is also a proud member of Exception MD Network – a global network of specialists, and health care professionals who have chosen to focus their efforts on cutting-edge medicine that is both patient-centered and result-driven.
AR
HY
ZH-CN
EN
DE
EL
IT
FA
PT
ES
TR
JP
